NDC 11822-7005 Fluticasone Propionate

Fluticasone Propionate

NDC Product Code 11822-7005

NDC 11822-7005-1

Package Description: 1 BOTTLE, SPRAY in 1 CARTON > 60 SPRAY, METERED in 1 BOTTLE, SPRAY

NDC 11822-7005-2

Package Description: 1 BOTTLE, SPRAY in 1 CARTON > 120 SPRAY, METERED in 1 BOTTLE, SPRAY

NDC 11822-7005-3

Package Description: 2 BOTTLE, SPRAY in 1 CARTON > 120 SPRAY, METERED in 1 BOTTLE, SPRAY

NDC Product Information

Fluticasone Propionate with NDC 11822-7005 is a a human over the counter drug product labeled by Rite Aid Corporation. The generic name of Fluticasone Propionate is fluticasone propionate. The product's dosage form is spray, metered and is administered via nasal form.

Labeler Name: Rite Aid Corporation

Dosage Form: Spray, Metered - A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Fluticasone Propionate Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.


Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Nasal - Administration to the nose; administered by way of the nose.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Rite Aid Corporation
Labeler Code: 11822
FDA Application Number: ANDA208150 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: ANDA - A product marketed under an approved Abbreviated New Drug Application. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 10-10-2019 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2020 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Information for Patients

Fluticasone Nasal Spray

Fluticasone Nasal Spray is pronounced as (floo tik' a sone)

Why is fluticasone nasal spray medication prescribed?
Nonprescription fluticasone nasal spray (Flonase Allergy) is used to relieve symptoms of rhinitis such as sneezing and a runny, stuffy, or itchy nose and itchy, watery ey...
[Read More]

* Please review the disclaimer below.